Cefpodoxime & Potassium Clavulanate Oral Suspension – Potent Shield Against Resistant Bacterial Infections.
VANTIL CL This dual combination of Cefpodoxime 100 mg + Clavulanic Acid 62.50mg with Water is formulated to treat moderate to severe bacterial infections. Cefpinhibitshibiting bacterial cell wall synthesis, while Clavulanic Acid neutralizes β-lactamase enzymes, preventing drug resistance. The synergy extends coverage to β-lactamase-producing organisms, improving therapeutic outcomes in difficult-to-treat infections.
Recommended By Specialists:
✅General Physicians: It is preferred to treat the disease associated with common respiratory and urinary tract infections.
✅Pulmonologists: It is preferred to treat the disease associated with lower respiratory tract infections (bronchitis, pneumonia).\
✅ENT Specialists –: It is preferred to treat the disease associated with sinusitis, pharyngitis, otitis media
Key benefits of Cefpodoxime & Potassium Clavulanate Oral Suspension – VANTIL CL EXTRA:
✅Broad-Spectrum Activity with β-Lactamase Inhibition – Cefpodoxime, a 3rd-generation cephalosporin, targets gram-positive and gram-negative pathogens, while Clavulanic acid inhibits β-lactamase enzymes, restoring efficacy against resistant strains.
✅Enhanced Efficacy in Respiratory and Urinary Infections – Effective against common pathogens causing ENT, lower respiratory tract, and UTI infections, even those with partial resistance.
✅Improved Clinical Outcomes in Recurrent or Complicated Infections – The dual mechanism ensures a higher bacterial eradication rate and reduced treatment failures in chronic and resistant cases.
INDICATIONS:
✅Upper & Lower Respiratory Tract Infections
✅ENT Infections (Sinusitis, Otitis Media)
✅Urinary Tract Infections
✅Skin & Soft Tissue Infections











